` 688161 (Shandong Weigao Orthopaedic Device Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

S
688161
vs
S
Shanghai Composite

Over the past 12 months, Shandong Weigao Orthopaedic Device Co Ltd has underperformed Shanghai Composite, delivering a return of +14% compared to the Shanghai Composite's +25% growth.

Stocks Performance
688161 vs Shanghai Composite

Loading
688161
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
688161 vs Shanghai Composite

Loading
688161
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
688161 vs Shanghai Composite

Loading
688161
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Shandong Weigao Orthopaedic Device Co Ltd vs Peers

Shanghai Composite
688161
LEG
PMT
DFS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shandong Weigao Orthopaedic Device Co Ltd
Glance View

Market Cap
12B CNY
Industry
Health Care

Nestled in the bustling economic landscape of China, Shandong Weigao Orthopaedic Device Co Ltd has carved a respected niche for itself in the realm of medical equipment. The company, founded as a subsidiary of the larger Weigao Group, specializes in the design, production, and distribution of orthopedic devices. Its journey starts with an unwavering commitment to incorporating advanced technology into healthcare solutions. Shandong Weigao has honed its focus on spinal, trauma, and joint-related products, ensuring that its offerings meet international standards and cater to both domestic and global markets. Operating within an industry where precision and reliability are paramount, the company has leveraged a well-established network to distribute its products to hospitals, clinics, and healthcare facilities, thus embedding its roots deeply within the healthcare infrastructure. This thriving enterprise makes money by delivering value through its diverse product portfolio tailored to meet the complex and varied needs of orthopedic treatments. Its revenue model is centered around a combination of direct sales, strategic partnerships, and long-term contracts with healthcare providers. By engaging in continuous research and development, Shandong Weigao not only expands its product lines but also enhances existing solutions, ensuring they remain cutting-edge. This emphasis on innovation has enabled the company to maintain a competitive edge in a rapidly evolving market, positioning itself as a leader in China’s orthopedic device industry. Through strategic market penetration and an adept understanding of regulatory landscapes, Shandong Weigao Orthopaedic Device Co Ltd not only sustains its growth but also contributes significantly to the advancements in orthopedic healthcare.

Intrinsic Value
27.42 CNY
Overvaluation 8%
Intrinsic Value
Price
S
Back to Top